Factors associated with HIV viral suppression among children and adults receiving antiretroviral therapy in Malawi in 2021: Evidence from the Laboratory Management Information System
Authors:
- 14 June 2022
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 27 (7) , 639-646
Abstract
Objective: To describe the prevalence of HIV viral suppression and assess the factors associated with HIV viral suppression among persons receiving antiretroviral therapy (ART) in Malawi in 2021.Methods: Implementation study using routinely collected patient‐level HIV RNA‐PCR test result data extracted from the national Laboratory Management Information System (LIMS) database managed by the Department of HIV/AIDS in 2021. We calculated frequencies, proportions and odds ratios (OR) of HIV viral suppression with their associated 95% confidence intervals (95%CIs). We performed a random‐effects logistic regression to determine the risk factors associated with HIV viral suppression among ART patients, controlling for the spatial autocorrelation between districts and adjusting for other variables.Results: We evaluated 515,797 adults and children receiving ART and having a viral load test in 2021. Of these, 92.8% had HIV viral suppression. ART patients living in urban areas had lower likelihood of HIV viral suppression than those living in rural areas (adjusted OR [aOR] = 0.95, 95%CI: 0.92–0.99, p = 0.01). There was an increasing trend in HIV viral suppression with increasing ART duration. Routine VL monitoring samples were 39% more likely to have suppressed VL values than confirmatory HIV VL monitoring samples (aOR = 1.39; 95%CI: 1.34–1.43, p < 0.001).Conclusion: This is the first national analysis of Malawi HIV VL data from LIMS. Our findings show the need to particularly consider the urban residents, those below 20 years, males, those on ART for less than a year as well as those on specific ARV regimens in order to persistently suppress HIV VL and consequently achieve the goal of achieving HIV VL suppression by 2030.Keywords
All Related Versions
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (163878)
This publication has 14 references indexed in Scilit:
- High levels of viral load monitoring and viral suppression under Treat All in Rwanda – a cross‐sectional studyJournal of the International AIDS Society, 2020
- Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia, 2019: Retrospective Cohort StudyAIDS Research and Treatment, 2020
- What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?Journal of the International AIDS Society, 2020
- Point‐of‐care viral load monitoring: outcomes from a decentralized HIV programme in MalawiJournal of the International AIDS Society, 2019
- Treating all people living with HIV in sub-Saharan Africa: a new era calling for new approachesJournal of Virus Eradication, 2018
- Does Economic Strengthening Improve Viral Suppression Among Adolescents Living with HIV? Results From a Cluster Randomized Trial in UgandaAIDS and Behavior, 2018
- Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South AfricaInternational Journal of STD & AIDS, 2018
- Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015BMC Infectious Diseases, 2017
- Rural–Urban Differences in HIV Viral Loads and Progression to AIDS among New HIV CasesSouthern Medical Journal, 2015
- Are They Really Lost? “True” Status and Reasons for Treatment Discontinuation among HIV Infected Patients on Antiretroviral Therapy Considered Lost to Follow Up in Urban MalawiPLOS ONE, 2013